Pinned Tweet
Today's third quarter results demonstrate Clover's technology-powered differentiation and how earlier identification and management of chronic disease, strong growth, and increasing profitability can reinforce one another.
Some highlights:
$62M YTD GAAP Net Income
YTD average ership growth +49% YoY
Improved FY 2026 guidance
Flagship PPO received 5 Stars for Payment Year 2028
Read more: investors.cloverhealth.com/static-files/a…
Some highlights:
$62M YTD GAAP Net Income
YTD average ership growth +49% YoY
Improved FY 2026 guidance
Flagship PPO received 5 Stars for Payment Year 2028
Read more: investors.cloverhealth.com/static-files/a…
10
13
91
4,237
Following yesterday’s earnings announcement, we’re pleased to recognize Clay Thornton’s appointment as Chief Financial Officer and Joe Oldakowski’s appointment as Chief Accounting Officer of Clover Health.
Both bring deep expertise and disciplined leadership to their roles. Congratulations!
Both bring deep expertise and disciplined leadership to their roles. Congratulations!
1
6
76
2,967
We’re proud to be recognized among U.S. News & World Report's Best Medicare Advantage ratings for 2027 in New Jersey, Georgia, and South Carolina!
Clover earned the highest scores in Care Continuity in all 3 states.
Learn more: investors.cloverhealth.com/news-releases/…
Y0129_26EX091F1_C
Clover earned the highest scores in Care Continuity in all 3 states.
Learn more: investors.cloverhealth.com/news-releases/…
Y0129_26EX091F1_C
8
20
124
9,615
Clover Health’s MA PPO plans received a 5-Star rating and its HMO plans received a 4.5-Star rating for 2027. We’re proud of what this means for our ability to continue delivering strong benefits, affordability and wide provider choice—while supporting reforms that better align Stars with meaningful improvements in members’ health.
For the third year in a row, Clover has continued its market-leading performance on core HEDISⓇ* measures with a score of 4.82 out of 5 Stars,** again ranking #1 among non-SNP PPO plans with over 2,000 members.
For the 2027 Star Ratings, Clover’s overall rating was driven by improvements across Stars domains. This performance reflects the strength of our care model, powered by @counterparthlth, which surfaces relevant information to help physicians identify care needs and support better-informed clinical decisions.
Read more: investors.cloverhealth.com/news-releases/…
* HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)
** This analysis focuses on performance by non-SNP PPO plans with over 2,000 lives as of September 1, 2024, 2025, and 2026 on HEDIS measures applicable to non-SNPs that were used for CMS’s MY 2023, MY2024, and MY 2025 Star ratings, applying the measure ranges used by CMS.
For the third year in a row, Clover has continued its market-leading performance on core HEDISⓇ* measures with a score of 4.82 out of 5 Stars,** again ranking #1 among non-SNP PPO plans with over 2,000 members.
For the 2027 Star Ratings, Clover’s overall rating was driven by improvements across Stars domains. This performance reflects the strength of our care model, powered by @counterparthlth, which surfaces relevant information to help physicians identify care needs and support better-informed clinical decisions.
Read more: investors.cloverhealth.com/news-releases/…
* HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)
** This analysis focuses on performance by non-SNP PPO plans with over 2,000 lives as of September 1, 2024, 2025, and 2026 on HEDIS measures applicable to non-SNPs that were used for CMS’s MY 2023, MY2024, and MY 2025 Star ratings, applying the measure ranges used by CMS.
13
36
209
16,447
Clover Health Q3 2026 earnings results are set for release after market on Wednesday, November 4, 2026.
Have a question for our leadership team? Our CLOV Supplemental Q&A submissions form is now open and we plan to publish responses the week following earnings.
Please submit all questions via our IR website anytime between now and 4:30pm ET on Wednesday, October 28th. We look forward to hearing from you!
Access our Q&A submissions form here: forms.gle/oq9WW7GtNwygDc…
Have a question for our leadership team? Our CLOV Supplemental Q&A submissions form is now open and we plan to publish responses the week following earnings.
Please submit all questions via our IR website anytime between now and 4:30pm ET on Wednesday, October 28th. We look forward to hearing from you!
Access our Q&A submissions form here: forms.gle/oq9WW7GtNwygDc…
4
9
69
4,351
For 2027, Clover is leaning into what makes our MA model different: meaningful PPO choice, affordable access to preventive care, and a model powered by Clover Assistant that supports physicians with relevant patient information to identify care needs and make better-informed the MA market continues to change, we remain focused on delivering meaningful member value and giving seniors access, flexibility and choice in how they receive care.
More: investors.cloverhealth.com/news-releases/…
Clover Health is a PPO and HMO organization with a Medicare contract. Enrollment in Clover Health depends on contract renewal.
Y0129_26EX091A_M
More: investors.cloverhealth.com/news-releases/…
Clover Health is a PPO and HMO organization with a Medicare contract. Enrollment in Clover Health depends on contract renewal.
Y0129_26EX091A_M
1
9
78
3,077
We’re pleased to welcome former U.S. Senator Robert “Bob” Torricelli and Dr. Brian J. Miller to Clover Health’s Board of Directors. Their experience across public policy, medicine, Medicare and business brings valuable perspectives to our Board as Clover continues to grow.
Read more: investors.cloverhealth.com/news-releases/…
Read more: investors.cloverhealth.com/news-releases/…
4
10
86
5,633
Thanks to those who took the time to submit questions for this quarter’s Supplemental Q&A.
For this round, our CEO Andrew Toy and Interim CFO Clay Thornton have answered a selection of questions that we believe help provide additional perspective on our second quarter 2026 results, our updated outlook for the balance of 2026, and the longer-term direction of the business.
These questions reflect both submissions received through our shareholder portal and recurring topics we've heard in conversations with investors and at industry events.
Read more: investors.cloverhealth.com/static-files/b…
For this round, our CEO Andrew Toy and Interim CFO Clay Thornton have answered a selection of questions that we believe help provide additional perspective on our second quarter 2026 results, our updated outlook for the balance of 2026, and the longer-term direction of the business.
These questions reflect both submissions received through our shareholder portal and recurring topics we've heard in conversations with investors and at industry events.
Read more: investors.cloverhealth.com/static-files/b…
6
6
60
4,982
Today’s 2Q26 earnings release shows that a wide-network, full-risk Medicare Advantage model can deliver better health outcomes, meaningful growth, and increasing profitability at the same time.
Some Highlights:
- Delivered strong second quarter GAAP Net Income alongside g Medicare Advantage membership growth
- Improved Full Year 2026 guidance across all metrics
- Increasing confidence in 2027 outlook, supported by strong cohort development, continued clinical engagement, and the added flexibility of a 4.5 Star payment year
Here’s the full release on this quarter: investors.cloverhealth.com/static-files/8…
Some Highlights:
- Delivered strong second quarter GAAP Net Income alongside g Medicare Advantage membership growth
- Improved Full Year 2026 guidance across all metrics
- Increasing confidence in 2027 outlook, supported by strong cohort development, continued clinical engagement, and the added flexibility of a 4.5 Star payment year
Here’s the full release on this quarter: investors.cloverhealth.com/static-files/8…
11
21
153
11,760
At today’s @CMSGov Health Tech Ecosystem GA release event, we're proud to share that Clover Health, powered by @counterparthlth, is now fully GA on a CMS-aligned network, seamlessly and securely responding to requests and fulfilling our first-wave CMS payer pledge.
We’re also arly adopters of the Real-Time Benefits Pledge and the Price Transparency Pledge. These efforts align with our ongoing efforts to provide clearer, more personalized cost and coverage information that supports better conversations between patients and physicians.
We’re also arly adopters of the Real-Time Benefits Pledge and the Price Transparency Pledge. These efforts align with our ongoing efforts to provide clearer, more personalized cost and coverage information that supports better conversations between patients and physicians.
6
17
93
11,189
Clover Health Q2 2026 earnings results are set for release after market on Wednesday, August 5, 2026.
Our CLOV Supplemental Q&A submissions form is now open and we plan to publish responses the week following earnings. Please submit all questions for CEO Andrew Toy and Interim CFO Clay Thornton via our IR website anytime between now and 4:30pm ET on Wednesday, July 29. We look forward to hearing from you!
Access our Q&A submissions form here: forms.gle/VeXhDofMKsnHnL…
Our CLOV Supplemental Q&A submissions form is now open and we plan to publish responses the week following earnings. Please submit all questions for CEO Andrew Toy and Interim CFO Clay Thornton via our IR website anytime between now and 4:30pm ET on Wednesday, July 29. We look forward to hearing from you!
Access our Q&A submissions form here: forms.gle/VeXhDofMKsnHnL…
2
9
71
5,795
At Clover Health, we’re focused on helping providers deliver more proactive, coordinated care for members with complex needs.
@counterparthlth's latest whitepaper offers a closer look at how Counterpart Assistant, its AI-powered physician enablement platform, supports that work during one of the most important moments in care: the transition after hospitalization or emergency department visit.
Read the whitepaper here: cdn.counterparthealth.com/whitepapers/co…
Read the press release: investors.cloverhealth.com/news-releases/…
@counterparthlth's latest whitepaper offers a closer look at how Counterpart Assistant, its AI-powered physician enablement platform, supports that work during one of the most important moments in care: the transition after hospitalization or emergency department visit.
Read the whitepaper here: cdn.counterparthealth.com/whitepapers/co…
Read the press release: investors.cloverhealth.com/news-releases/…
After a hospitalization or emergency department visit, timely follow-up matters.
In a new real-world analysis, Counterpart Health compared members attributed to Counterpart Assistant (CA)-enabled PCPs with @CloverHealth members attributed to PCPs not using CA, examining k care transition outcomes, including two HEDIS® quality measures.
Among the findings, CA-enabled PCPs showed better HEDIS® post-acute performance, including 33% higher discharge information receipt and an 11% higher rate of post-discharge medication reconciliation, underscoring the role of AI-enabled workflows in high-risk care transitions.
Read more: cdn.counterparthealth.com/whitepapers/co…
Read the press release: investors.cloverhealth.com/news-releases/…
2
8
75
5,549
What does it look like when growth and quality aren't competing priorities, but the same?
Clover's CEO of Medicare Advantage Jamie Reynoso joined @alvarezmarsal's Significant Healthcare Voices podcast to talk about our 53% AEP growth and what it takes to lead in a market where others are retreating.
Listen to the conversation below: alvarezandmarsal.com/insights/signi…
Clover's CEO of Medicare Advantage Jamie Reynoso joined @alvarezmarsal's Significant Healthcare Voices podcast to talk about our 53% AEP growth and what it takes to lead in a market where others are retreating.
Listen to the conversation below: alvarezandmarsal.com/insights/signi…
0
8
67
6,011
Thanks to those who took the time to submit questions for this quarter’s Supplemental Q&A. For this round, our CEO Andrew Toy and Interim CFO Clay Thornton have answered a selection of questions that we believe help further address key topics, including our first quarter performance and the longer-term direction of the business.
These questions reflect submissions received through our shareholder portal, as well as recurring themes from recent conversations with investors and participants at industry conferences.
Read more: investors.cloverhealth.com/static-files/0…
These questions reflect submissions received through our shareholder portal, as well as recurring themes from recent conversations with investors and participants at industry conferences.
Read more: investors.cloverhealth.com/static-files/0…
5
6
61
2,880
What does healthcare AI look like when a computer scientist-led health plan holds the risk? Our CEO @andrewtoy joined @BainCapital's Future of Healthcare AI podcast, on why the payer is one of the few vantage points from which you can truly re-architect healthcare with technology.
Also: why the right 80s movie for agentifying solutions isn't Terminator.
🎙 baincapital.com/healthcare/med…
Also: why the right 80s movie for agentifying solutions isn't Terminator.
🎙 baincapital.com/healthcare/med…
4
15
95
7,779
🎉 We've got a Jeopardy! champion in our midst.
Huge congratulations to our very own, Tristan Williams, Staff Data Scientist, who won last night’s episode of Jeopardy! Turns out data scientists are pretty good at knowing things.
Tristan returns today, Thursday May 7, for round two. Tune in to see if he can break the one-day champion curse! 📺
We're cheering you on, Tristan! 🟦 🟦 🟦
Huge congratulations to our very own, Tristan Williams, Staff Data Scientist, who won last night’s episode of Jeopardy! Turns out data scientists are pretty good at knowing things.
Tristan returns today, Thursday May 7, for round two. Tune in to see if he can break the one-day champion curse! 📺
We're cheering you on, Tristan! 🟦 🟦 🟦
5
4
78
7,731
Today's 1Q26 earnings release demonstrates how market-leading growth and GAAP profitability can scale together at full risk in Medicare Advantage. Highlights:
- We achieved positive GAAP Net Income in first-quarter 2026, marked by strong performance across our key metrics: Total DA, and Consolidated Gross Profit.
- We had market-leading MA membership growth with underlying trends tracking in line with expectations.
- We expect to meet or exceed our full year 2026 outlook across all metrics, including achieving our first full year of GAAP Net Income profitability.
Here’s the full release on what we delivered this quarter, in Clay Thornton’s first earnings as our Interim CFO:
investors.cloverhealth.com/static-files/1…
- We achieved positive GAAP Net Income in first-quarter 2026, marked by strong performance across our key metrics: Total DA, and Consolidated Gross Profit.
- We had market-leading MA membership growth with underlying trends tracking in line with expectations.
- We expect to meet or exceed our full year 2026 outlook across all metrics, including achieving our first full year of GAAP Net Income profitability.
Here’s the full release on what we delivered this quarter, in Clay Thornton’s first earnings as our Interim CFO:
investors.cloverhealth.com/static-files/1…
7
19
116
74,865